NDAC meeting on calendar
This article was originally published in The Tan Sheet
Executive Summary
FDA tentatively schedules a joint meeting of the Nonprescription Drug Advisory Committee and the Drug Safety and Risk Management Advisory Committee Sept. 14, the agency's Web site says. If the meeting is scheduled, the subject will not be known until FDA posts a Federal Register notice or updates meeting materials on its site. NDAC last met in June 2009, also with DSRM and the Life Support Drugs committee, to discuss acetaminophen (1"The Tan Sheet" Jan. 4, 2010, In Brief)
You may also be interested in...
FDA lays out 2010 advisory committee slate
The agency's tentative 1schedule for advisory committee meetings includes a Food meeting May 20-21 and Pediatric sessions in March, June, September and December. FDA's calendar, published Dec. 30 in the Federal Register, also pencils in meetings for both the Risk Communication panel and Science Board in February, May, August and November. The Nonprescription Drug Advisory Committee has not had tentative or firm meeting dates set. NDAC last met in June 2009 for a joint session regarding acetaminophen with the Drug Safety and Risk Management and Anesthetic and Life Support Drugs committees (2"The Tan Sheet" July 6, 2009)
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.